Grant: Discovery Grants Program - Individual
University of Ottawa
$24,000.00
Synthesis and Characterization of Tunable Chitosan and Collagen Hydrogel Derivatives
FY 2015-16
Summary
Heart disease (#1 killer in Western world) and diabetes persist as major health problems, and their global
prevalence is expected to rise in the coming years. Current therapies only delay or prevent their progression. Laboratory experiments and recent clinical trials show that cell-based therapies are promising for treating these conditions. The implications of this are causing great excitement. There is much optimism that cell therapy will one day be used to grow new tissues in patients to replace the diseased ones. Despite the enthusiasm, cell therapy is hindered by a low rate of engraftment and low persistence of cells in the target tissue. Also, the environment the cells are delivered to (the diseased tissue) does not always allow the cells to function properly. Therefore, strategies to enhance the therapeutic potential of the transplanted cells are needed. Tissue engineered scaffolds have demonstrated an ability to boost cell therapy. However, improvements in these materials are still needed. It is imperative that we develop novel, powerful scaffolds that can optimize cell engraftment, function and tissue regeneration.
In this project, we will develop new biomaterials termed ""microgels"". Microgels are small soft-material
particles that can be linked into networks. These are attractive materials for tissue engineering applications because of their physical properties and biocompatibility. We expect that the large surface area of microgels will improve tissue integration and facilitate controlled delivery of cells. The microgels are injectable, and their architecture can be controlled - another advantage of microgels. Importantly, it is also easy to add functional groups to microgels for improved cell-material interactions. We will design and synthesize various microgels and evaluate their effects on cell adhesion and function in lab culture experiments. In the end, we expect to have produced advanced biomaterials that will be better able to promote cell survival and control their function.
Program
Discovery Grants Program - Individual
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
342107-2012
Name nom
Suuronen, Erik
Department département
Medicine, Faculty of
Organization id
28
Institution établissement
University of Ottawa
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2015
Competition year année de concours
2012
Award amount
24000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1511
Committee name en
Materials and Chemical Engineering
Committee name fr
Génie chimique et des matériaux
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
2006
Research subject group en
Materials science and technology
Research subject group fr
Science et technologie des matériaux
Research subject en
Biomaterials
Research subject fr
Biomatériaux
Partie
4
Nb partie
5
Application title
Synthesis and Characterization of Tunable Chitosan and Collagen Hydrogel Derivatives
Keyword
NSERC
Application summary
Heart disease (#1 killer in Western world) and diabetes persist as major health problems, and their global
prevalence is expected to rise in the coming years. Current therapies only delay or prevent their progression. Laboratory experiments and recent clinical trials show that cell-based therapies are promising for treating these conditions. The implications of this are causing great excitement. There is much optimism that cell therapy will one day be used to grow new tissues in patients to replace the diseased ones. Despite the enthusiasm, cell therapy is hindered by a low rate of engraftment and low persistence of cells in the target tissue. Also, the environment the cells are delivered to (the diseased tissue) does not always allow the cells to function properly. Therefore, strategies to enhance the therapeutic potential of the transplanted cells are needed. Tissue engineered scaffolds have demonstrated an ability to boost cell therapy. However, improvements in these materials are still needed. It is imperative that we develop novel, powerful scaffolds that can optimize cell engraftment, function and tissue regeneration.
In this project, we will develop new biomaterials termed ""microgels"". Microgels are small soft-material
particles that can be linked into networks. These are attractive materials for tissue engineering applications because of their physical properties and biocompatibility. We expect that the large surface area of microgels will improve tissue integration and facilitate controlled delivery of cells. The microgels are injectable, and their architecture can be controlled - another advantage of microgels. Importantly, it is also easy to add functional groups to microgels for improved cell-material interactions. We will design and synthesize various microgels and evaluate their effects on cell adhesion and function in lab culture experiments. In the end, we expect to have produced advanced biomaterials that will be better able to promote cell survival and control their function.